glp-1 and anxiety agonists side effects The risk of depression, anxiety, suicidal behavior in patients with obesity on glucagon like peptide-1 receptor agonist therapy Exploring The Gut-Brain Connection ANXIETY AND DEPRESSION ON A

Oral GLP-1 medications reduce some barriers associated with injectable administration particularly convenience and needle aversion and may broaden uptake among patients who previously declined injectable therapy

App NL-G-F mouse also exhibited inflammatory events similar to GCLC-KO mouse

So true specifically in patients with type two diabetes

Tang H, Lu Y, Okun MS, Donahoo WT, Ramirez-Zamora A, Wang F, Huang Y, Armstrong M, Svensson M, Virnig BA, DeKosky ST, Bian J, Guo J (2024) Glucagon-like Peptide-1 receptor agonists and risk of Parkinsons Disease in patients with type 2 diabetes: a Population-based Cohort Study

A slow stroll around the block works

however, most evidence is indirect and not derived from dedicated randomized heart failure trials